Mediclinic International PLC (LON:MDC)’s stock price reached a new 52-week high during trading on Friday following a dividend announcement from the company. The stock traded as high as GBX 396.20 ($5.18) and last traded at GBX 396.20 ($5.18), with a volume of 531204 shares changing hands. The stock had previously closed at GBX 377 ($4.93).
The newly announced dividend which will be paid on Tuesday, December 17th. Investors of record on Thursday, December 5th will be given a dividend of GBX 3.20 ($0.04) per share. The ex-dividend date of this dividend is Thursday, December 5th. This represents a yield of 0.85%. Mediclinic International’s dividend payout ratio (DPR) is -0.39%.
Several brokerages recently issued reports on MDC. UBS Group restated a “buy” rating and set a GBX 385 ($5.03) target price (down from GBX 395 ($5.16)) on shares of Mediclinic International in a research report on Monday, October 14th. Jefferies Financial Group reaffirmed a “buy” rating on shares of Mediclinic International in a report on Friday. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Mediclinic International presently has a consensus rating of “Buy” and an average target price of GBX 374.75 ($4.90).
Mediclinic International Company Profile (LON:MDC)
Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers acute care, specialist-orientated, and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 17 private acute care hospitals and 4 clinics with approximately 1,805 inpatient beds in Switzerland; 49 acute care private hospitals and 2 day clinics in South Africa, and 3 hospitals in Namibia with approximately 8,131 inpatient beds; and 6 acute care private hospitals and 22 clinics with approximately 748 inpatient beds in the United Arab Emirates.
Recommended Story: How to Track your Portfolio in Google Finance
Receive News & Ratings for Mediclinic International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediclinic International and related companies with MarketBeat.com's FREE daily email newsletter.